Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.690
-0.130 (-7.14%)
At close: Aug 28, 2026, 4:00 PM EDT
1.709
+0.019 (1.11%)
After-hours: Aug 28, 2026, 7:27 PM EDT

Lisata Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.4415.9616.2122.5932.1524.65
Short-Term Investments
--15.0427.9437.0770.32
Cash & Short-Term Investments
10.4415.9631.2550.5469.2394.97
Cash Growth
-52.47%-48.93%-38.17%-27.00%-27.11%174.69%
Accounts Receivable
--0.9---
Other Receivables
0.20.70.6-0.7-
Receivables
0.20.71.5-0.7-
Prepaid Expenses
0.371.051.833.391.951.21
Total Current Assets
11.0117.734.5853.9271.8896.18
Property, Plant & Equipment
0.010.020.210.480.780.79
Other Intangible Assets
--0.190.260.33-
Other Long-Term Assets
-0.020.020.020.040.04
Total Assets
11.0317.743554.6973.0397.01

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.841.021.282.422.661.93
Accrued Expenses
2.052.054.1943.552.36
Current Portion of Leases
--0.140.170.180.23
Other Current Liabilities
0.1-----
Total Current Liabilities
2.993.075.616.596.384.52
Long-Term Leases
---0.140.310.49
Other Long-Term Liabilities
0.050.070.070.070.02-
Total Liabilities
3.043.145.696.86.715.01

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010
Additional Paid-In Capital
581.03580.24578.42576.97574.55546.04
Retained Earnings
-572.07-564.65-548.07-528.08-507.24-453.02
Treasury Stock
-0.71-0.71-0.71-0.71-0.71-0.71
Comprehensive Income & Other
-0.02-0.04-0.08-0.04-0.03-0.07
Total Common Equity
8.2414.8629.5748.1566.5892.25
Minority Interest
-0.25-0.25-0.25-0.25-0.25-0.25
Shareholders' Equity
7.9914.629.3247.8966.3292
Total Liabilities & Equity
11.0317.743554.6973.0397.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
--0.140.310.490.71
Net Cash (Debt)
10.4415.9631.1150.2368.7494.26
Net Cash Growth
-52.36%-48.71%-38.07%-26.93%-27.07%177.64%
Net Cash Per Share
1.171.843.736.2213.2725.56
Filing Date Shares Outstanding
9.019.0327.78.3184.04
Total Common Shares Outstanding
9.128.838.418.157.873.99
Working Capital
8.0314.6328.9747.3365.4991.66
Book Value Per Share
0.901.683.525.918.4623.14
Tangible Book Value
8.2414.8629.3847.8966.2492.25
Tangible Book Value Per Share
0.901.683.495.888.4223.14
Machinery
0.490.490.590.590.610.34
Leasehold Improvements
--0.070.070.10.09
SEC Filings: 10-K · 10-Q